dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024

The shareholders in attendance, together with the votes represented by independent proxy, represented 77.78% of shares. The shareholders in attendance, together with the votes represented by independent proxy, represented 77.78% of shares. About dsm-firmenich As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions,...
Switzerland, (informazione.it - comunicati stampa - information technology)

The shareholders in attendance, together with the votes represented by independent proxy, represented 77.78% of shares.

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.

For more information, please contact:

dsm-firmenich media enquiries: [email protected]

dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024

dsm-firmenich investor relations enquiries: [email protected]

Forward-looking statements

This press release may contain forward-looking statements with respect to dsm-firmenich's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.

Cision View original content:https://www.prnewswire.co.uk/news-releases/dsm-firmenich-shareholders-approve-all-resolutions-at-annual-general-meeting-2024-302138009.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili